Relieving pressure in Slovakia

Amlozek, the drug it wants to export, appeared on the Polish market in 1998. It found its place among the top ten selling drugs in this country and is used by about 450,000 patients a month suffering from high blood pressure. Adamed's annual income from selling Amlozek is about zł.84 million and the company's exports for 2004 will amount to about zł.7 million, almost 50% more than in 2003. Its projected annual revenues for 2004 are zł.158 million with an expected net profit around zł.9 million. (Poland A.M.)